Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anal Cancer Patients”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00066430
What this trial is testing

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Who this might be right for
Anal CancerPrecancerous Condition
AIDS Malignancy Consortium 18
Not applicableUnknownNCT01388257
What this trial is testing

Anal Crohn Fistula Surgery

Who this might be right for
Crohn DiseaseFistulaAnoperineal Fistula+1 more
French Society of Coloproctology 180
Not applicableStudy completedNCT05682157
What this trial is testing

Paula Method of Exercises in Patients With LARS Syndrome:Randomized Controlled Trial

Who this might be right for
Low Anterior Resection Syndrome
Hadassah Medical Organization 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04444921
What this trial is testing

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 205
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)Ended earlyNCT01408407
What this trial is testing

Alkagin Paste in the Prevention of Radiation Dermatitis

Who this might be right for
Anus NeoplasmsRectal NeoplasmsUrogenital Neoplasms
Sir Mortimer B. Davis - Jewish General Hospital 2
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Early research (Phase 1)Study completedNCT02199236
What this trial is testing

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Who this might be right for
Rectal or Anal Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05040815
What this trial is testing

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Who this might be right for
Anal Canal Cancer
AHS Cancer Control Alberta 45
Not applicableLooking for participantsNCT06366841
What this trial is testing

Stigma and Psychological profilE in REctal-anal caNcer pAtients

Who this might be right for
Rectal CancerAnal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 148
Testing effectiveness (Phase 2)UnknownNCT02488707
What this trial is testing

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

Who this might be right for
Rectal Cancer
Mansoura University 250
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Looking for participantsNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Load More Results